Triple
T5465251
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Avie Tevanian |
E122691
|
entity |
| Predicate | boardMemberOf |
P10
|
FINISHED |
| Object |
Nautilus Biotechnology
Nautilus Biotechnology is a life sciences company developing next-generation, high-throughput proteomics platforms to enable comprehensive analysis of the human proteome for research and drug discovery.
|
E523160
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Nautilus Biotechnology | Statement: [Avie Tevanian, boardMemberOf, Nautilus Biotechnology]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Nautilus Biotechnology Context triple: [Avie Tevanian, boardMemberOf, Nautilus Biotechnology]
-
A.
Vir Biotechnology
Vir Biotechnology is a clinical-stage immunology company focused on developing treatments and prophylactics for serious infectious diseases using antibody, T cell, and other immune-based technologies.
-
B.
Nanosphere, Inc.
Nanosphere, Inc. was a biotechnology company specializing in nanoparticle-based molecular diagnostic tests for detecting genetic and infectious diseases.
-
C.
Insitro
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
-
D.
Array BioPharma
Array BioPharma is a biopharmaceutical company known for developing targeted small-molecule cancer therapies, particularly in oncology and rare diseases.
-
E.
Verily Life Sciences LLC
Verily Life Sciences LLC is a health-focused research and technology company that develops tools and platforms to collect, organize, and analyze health data, particularly in areas like clinical research, precision health, and disease management.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Nautilus Biotechnology Triple: [Avie Tevanian, boardMemberOf, Nautilus Biotechnology]
Generated description
Nautilus Biotechnology is a life sciences company developing next-generation, high-throughput proteomics platforms to enable comprehensive analysis of the human proteome for research and drug discovery.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Nautilus Biotechnology Target entity description: Nautilus Biotechnology is a life sciences company developing next-generation, high-throughput proteomics platforms to enable comprehensive analysis of the human proteome for research and drug discovery.
-
A.
Vir Biotechnology
Vir Biotechnology is a clinical-stage immunology company focused on developing treatments and prophylactics for serious infectious diseases using antibody, T cell, and other immune-based technologies.
-
B.
Nanosphere, Inc.
Nanosphere, Inc. was a biotechnology company specializing in nanoparticle-based molecular diagnostic tests for detecting genetic and infectious diseases.
-
C.
Insitro
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
-
D.
Array BioPharma
Array BioPharma is a biopharmaceutical company known for developing targeted small-molecule cancer therapies, particularly in oncology and rare diseases.
-
E.
Verily Life Sciences LLC
Verily Life Sciences LLC is a health-focused research and technology company that develops tools and platforms to collect, organize, and analyze health data, particularly in areas like clinical research, precision health, and disease management.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69bd4643f16081908d7f29e08096115a |
completed | March 20, 2026, 1:06 p.m. |
| NER | Named-entity recognition | batch_69bd920590b481909b92091678ff1414 |
completed | March 20, 2026, 6:29 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69bf488b64d081908163edfff6484f5c |
completed | March 22, 2026, 1:40 a.m. |
| NEDg | Description generation | batch_69bf49ed2e2081908642f700d97943e9 |
completed | March 22, 2026, 1:46 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69bf4abbf2488190a30dd222d0de0470 |
completed | March 22, 2026, 1:49 a.m. |
Created at: March 20, 2026, 2:08 p.m.